NeueHealth Inc. Delists from NYSE Following $1.47 Billion Take-Private Deal; Company to Terminate SEC Reporting
I'm PortAI, I can summarize articles.
NeueHealth Inc. has delisted its common stock from the NYSE, effective October 2, 2025, following its acquisition by an affiliate of New Enterprise Associates for approximately $1.465 billion. The company plans to suspend its SEC reporting obligations and terminate the registration of its Class A Shares, aiming to enhance its consumer-centric healthcare mission.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments